The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 ...

Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia, while antipsychotics and drugs for diabetes are associated with an increased ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

A study reveals that smartwatch data can predict psychiatric illnesses, uncover genetic links, and improve treatment options, ...

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

Their current study reveals that having diabetes, exposure to traffic-related air pollution (in the form of nitrogen dioxide) ...

“The advantage of blarcamesine lies in its small oral formulation, which offers clinical benefits for cognition and neurodegeneration ... Alzheimer's disease, Parkinson's disease, schizophrenia ...

The UPV/EHU's Neurochemistry and Neurodegeneration group has come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents.

Genetic studies have strongly established a prominent role of α-synuclein (α- syn) missense and multiplication mutations in causing Parkinson's disease (PD). In neurons, α-syn is almost ...